These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20482672)

  • 21. A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.
    Sun W; Fan YZ; Zhang WZ; Ge CY
    J Exp Clin Cancer Res; 2011 Apr; 30(1):46. PubMed ID: 21529356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment.
    Costa FF; Seftor EA; Bischof JM; Kirschmann DA; Strizzi L; Arndt K; Bonaldo Mde F; Soares MB; Hendrix MJ
    Epigenomics; 2009 Dec; 1(2):387-98. PubMed ID: 20495621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The involvement of Notch signaling in melanoma vasculogenic mimicry.
    Vartanian A; Gatsina G; Grigorieva I; Solomko E; Dombrovsky V; Baryshnikov A; Stepanova E
    Clin Exp Med; 2013 Aug; 13(3):201-9. PubMed ID: 22627943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embryonic signaling in melanoma: potential for diagnosis and therapy.
    Strizzi L; Hardy KM; Kirsammer GT; Gerami P; Hendrix MJ
    Lab Invest; 2011 Jun; 91(6):819-24. PubMed ID: 21464823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination.
    Hendrix MJ; Seftor RE; Seftor EA; Gruman LM; Lee LM; Nickoloff BJ; Miele L; Sheriff DD; Schatteman GC
    Cancer Res; 2002 Feb; 62(3):665-8. PubMed ID: 11830517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.
    Sun B; Zhang S; Zhao X; Zhang W; Hao X
    Int J Oncol; 2004 Dec; 25(6):1609-14. PubMed ID: 15547697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
    Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
    J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
    Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
    Vartanian A; Stepanova E; Grigorieva I; Solomko E; Baryshnikov A; Lichinitser M
    Melanoma Res; 2011 Apr; 21(2):91-8. PubMed ID: 21389833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasculogenic mimicry: current status and future prospects.
    Zhang S; Zhang D; Sun B
    Cancer Lett; 2007 Sep; 254(2):157-64. PubMed ID: 17306454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
    Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
    Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.
    Itzhaki O; Greenberg E; Shalmon B; Kubi A; Treves AJ; Shapira-Frommer R; Avivi C; Ortenberg R; Ben-Ami E; Schachter J; Besser MJ; Markel G
    PLoS One; 2013; 8(2):e57160. PubMed ID: 23451174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
    Lissitzky JC; Parriaux D; Ristorcelli E; Vérine A; Lombardo D; Verrando P
    Cancer Res; 2009 Feb; 69(3):802-9. PubMed ID: 19176384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
    Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.
    Strizzi L; Abbott DE; Salomon DS; Hendrix MJ
    Cell Cycle; 2008 Jul; 7(13):1931-5. PubMed ID: 18604175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.
    Postovit LM; Margaryan NV; Seftor EA; Kirschmann DA; Lipavsky A; Wheaton WW; Abbott DE; Seftor RE; Hendrix MJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4329-34. PubMed ID: 18334633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
    Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
    Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low oxygen levels induce the expression of the embryonic morphogen Nodal.
    Quail DF; Taylor MJ; Walsh LA; Dieters-Castator D; Das P; Jewer M; Zhang G; Postovit LM
    Mol Biol Cell; 2011 Dec; 22(24):4809-21. PubMed ID: 22031289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of tumorigenic melanoma cells using ALDH.
    Boonyaratanakornkit JB; Yue L; Strachan LR; Scalapino KJ; LeBoit PE; Lu Y; Leong SP; Smith JE; Ghadially R
    J Invest Dermatol; 2010 Dec; 130(12):2799-808. PubMed ID: 20739950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.
    Tan LY; Mintoff C; Johan MZ; Ebert BW; Fedele C; Zhang YF; Szeto P; Sheppard KE; McArthur GA; Foster-Smith E; Ruszkiewicz A; Brown MP; Bonder CS; Shackleton M; Ebert LM
    Oncotarget; 2016 Jul; 7(29):46492-46508. PubMed ID: 27340778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.